Balance Sheet Universal Health Services, Inc.

Equities

UHS

US9139031002

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 11/07/2025 am IST			5-day change	1st Jan Change
184.05 ^USD	+0.82%		-0.23%	+2.58%

03/07	Universal Health Services, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08:00 AM
17/06	Leerink Partners Adjusts PT on Universal Health Services to $253 From $252, Maintains Outperform Rating	MT

f600aaf3e038e39b2.0A7XuLKzV-2OJWXfpkbmZOB7znl811folff9UbQCQ-Q.vD69-tTwFIfAXxemiwuwB9MygSYPjg7R0ZOkYf5wKKPiO-CB5PxhoKNSJA

Published financial data: UNIVERSAL HEALTH SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.16TCr	1.26TCr	1.34TCr	1.43TCr	1.58TCr
Total Revenues	1.16TCr	1.26TCr	1.34TCr	1.43TCr	1.58TCr
Cost of Goods Sold, Total	690.12Cr	759.11Cr	823.66Cr	864.03Cr	910.65Cr
Gross Profit	465.77Cr	505.1Cr	516.28Cr	564.17Cr	672.15Cr
Selling General & Admin Expenses, Total	12Cr	12Cr	13Cr	14Cr	15Cr
Depreciation & Amortization - (IS)	51Cr	53Cr	58Cr	57Cr	58Cr
Other Operating Expenses	267.18Cr	300.46Cr	338.82Cr	375.72Cr	430.52Cr
Other Operating Expenses, Total	329.83Cr	365.67Cr	410.17Cr	446.63Cr	503.65Cr
Operating Income	135.94Cr	139.43Cr	106.11Cr	117.54Cr	168.5Cr
Interest Expense, Total	-11Cr	-8.53Cr	-13Cr	-21Cr	-19Cr
Interest And Investment Income	36.52L	32.96L	21.78L	24.72L	33.25L
Net Interest Expenses	-11Cr	-8.2Cr	-13Cr	-20Cr	-18Cr
Income (Loss) On Equity Invest.	11L	62L	12L	9L	11L
Other Non Operating Income (Expenses)	20.66L	59.91L	-1.34Cr	-3.11Cr	-8L
EBT, Excl. Unusual Items	125.71Cr	132.45Cr	92Cr	94Cr	150.11Cr
Gain (Loss) On Sale Of Investments	-40L	-	-	-	-
Asset Writedown	-	-1.44Cr	-5.76Cr	-	-
Other Unusual Items	-10L	-1.68Cr	-	-	-31.58L
EBT, Incl. Unusual Items	125.21Cr	129.33Cr	87Cr	94Cr	149.79Cr
Income Tax Expense	30Cr	31Cr	21Cr	22Cr	33Cr
Earnings From Continuing Operations	95Cr	99Cr	66Cr	72Cr	116.31Cr
Net Income to Company	95Cr	99Cr	66Cr	72Cr	116.31Cr
Minority Interest	-88.37L	39.58L	1.86Cr	-15.12L	-2.1Cr
Net Income - (IS)	94Cr	99Cr	68Cr	72Cr	114.21Cr
Preferred Dividend and Other Adjustments	29.81L	20.59L	7L	3L	50T
Net Income to Common Incl Extra Items	94Cr	99Cr	67Cr	72Cr	114.2Cr
Net Income to Common Excl. Extra Items	94Cr	99Cr	67Cr	72Cr	114.2Cr
Per Share Items
Net EPS - Basic	11.06	11.99	9.23	10.35	17.16
Basic EPS - Continuing Operations	11.06	11.99	9.23	10.35	17.16
Basic Weighted Average Shares Outstanding	8.51Cr	8.25Cr	7.31Cr	6.93Cr	6.66Cr
Net EPS - Diluted	10.99	11.82	9.14	10.23	16.82
Diluted EPS - Continuing Operations	10.99	11.82	9.14	10.23	16.82
Diluted Weighted Average Shares Outstanding	8.56Cr	8.37Cr	7.38Cr	7.01Cr	6.79Cr
Normalized Basic EPS	9.13	10.08	8.15	8.46	13.78
Normalized Diluted EPS	9.08	9.94	8.07	8.36	13.51
Dividend Per Share	0.2	0.8	0.8	0.8	0.8
Payout Ratio	1.84	6.65	8.65	7.73	4.67
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	186.98Cr	192.75Cr	164.3Cr	174.34Cr	226.98Cr
EBITA	135.94Cr	139.43Cr	106.11Cr	117.54Cr	168.5Cr
EBIT	135.94Cr	139.43Cr	106.11Cr	117.54Cr	168.5Cr
EBITDAR	198.59Cr	204.64Cr	177.46Cr	188.44Cr	241.62Cr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	23.9	23.64	24.16	23.51	22.35
Current Domestic Taxes	31Cr	32Cr	21Cr	23Cr	36Cr
Current Foreign Taxes	1.4Cr	1.38Cr	1.47Cr	65.05L	1.1Cr
Total Current Taxes	33Cr	34Cr	23Cr	24Cr	37Cr
Deferred Domestic Taxes	-2.45Cr	-3.11Cr	-1.6Cr	-2.13Cr	-3.21Cr
Deferred Foreign Taxes	-24.96L	15.21L	-15.09L	33.67L	-13.18L
Total Deferred Taxes	-2.7Cr	-2.95Cr	-1.76Cr	-1.8Cr	-3.35Cr
Normalized Net Income	78Cr	83Cr	60Cr	59Cr	92Cr
Interest Capitalized	42.57L	44.11L	86L	2.44Cr	3.89Cr
Interest on Long-Term Debt	11Cr	8.97Cr	14Cr	23Cr	23Cr
Non-Cash Pension Expense	-19.04L	-19.97L	-14.99L	-77T	-4L
Supplemental Operating Expense Items
Net Rental Expense, Total	12Cr	12Cr	13Cr	14Cr	15Cr
Imputed Operating Lease Interest Expense	2.47Cr	1.95Cr	2.91Cr	4.91Cr	5.14Cr
Imputed Operating Lease Depreciation	9.13Cr	9.94Cr	10Cr	9.19Cr	9.5Cr
Stock-Based Comp., Other (Total)	6.59Cr	7.37Cr	8.53Cr	8.77Cr	9.93Cr
Total Stock-Based Compensation	6.59Cr	7.37Cr	8.53Cr	8.77Cr	9.93Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	122.45Cr	12Cr	10Cr	12Cr	13Cr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	122.45Cr	12Cr	10Cr	12Cr	13Cr
Accounts Receivable, Total	172.89Cr	174.66Cr	201.77Cr	223.83Cr	217.78Cr
Total Receivables	172.89Cr	174.66Cr	201.77Cr	223.83Cr	217.78Cr
Inventory	19Cr	21Cr	22Cr	22Cr	22Cr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	14Cr	19Cr	20Cr	24Cr	29Cr
Total Current Assets	328.19Cr	226.36Cr	253.73Cr	281.14Cr	281.63Cr
Gross Property Plant And Equipment	1.02TCr	1.11TCr	1.15TCr	1.22TCr	1.31TCr
Accumulated Depreciation	-451.28Cr	-489.64Cr	-516.74Cr	-565.25Cr	-607.11Cr
Net Property Plant And Equipment	570.96Cr	624.18Cr	637.31Cr	655.85Cr	699.09Cr
Long-term Investments	16Cr	18Cr	20Cr	17Cr	17Cr
Goodwill	388.27Cr	396.26Cr	390.95Cr	393.24Cr	393.29Cr
Other Intangibles, Total	8.26Cr	8.1Cr	7.81Cr	7.7Cr	7.63Cr
Deferred Tax Assets Long-Term	2.27Cr	4.57Cr	6.84Cr	8.56Cr	12Cr
Deferred Charges Long-Term	49.85L	65.25L	62.64L	69.74L	94.04L
Other Long-Term Assets, Total	34Cr	31Cr	32Cr	33Cr	35Cr
Total Assets	1.35TCr	1.31TCr	1.35TCr	1.4TCr	1.45TCr
Liabilities
Accounts Payable, Total	57Cr	66Cr	64Cr	61Cr	63Cr
Accrued Expenses, Total	109.81Cr	120.16Cr	112.16Cr	119.18Cr	144.95Cr
Current Portion of Long-Term Debt	33Cr	4.57Cr	7.84Cr	12Cr	3.48Cr
Current Portion of Leases	6.19Cr	6.72Cr	7.08Cr	7.46Cr	7.99Cr
Current Income Taxes Payable	4.44Cr	1.07Cr	46.08L	20.46L	1.42Cr
Other Current Liabilities	38Cr	6T	23.97L	72.86L	-
Total Current Liabilities	248.1Cr	198.41Cr	191.44Cr	201.33Cr	221.04Cr
Long-Term Debt	347.33Cr	406.53Cr	465.4Cr	471.61Cr	437.72Cr
Long-Term Leases	33Cr	38Cr	47Cr	45Cr	46Cr
Pension & Other Post Retirement Benefits	1.8Cr	2Cr	1.9Cr	2.2Cr	2.3Cr
Deferred Tax Liability Non Current	55.82L	-	-	-	-
Other Non Current Liabilities	76Cr	44Cr	47Cr	56Cr	63Cr
Total Liabilities	707.03Cr	689.54Cr	752.41Cr	776.57Cr	770.69Cr
Common Stock, Total	9L	8L	7L	7L	6L
Retained Earnings	626.82Cr	605.86Cr	592.95Cr	613.9Cr	665.84Cr
Comprehensive Income and Other	4.81Cr	3.03Cr	-96.68L	92.89L	72.01L
Total Common Equity	631.71Cr	608.97Cr	592.06Cr	614.9Cr	666.62Cr
Minority Interest	8.94Cr	11Cr	4.95Cr	5.29Cr	9.66Cr
Total Equity	640.65Cr	619.82Cr	597Cr	620.19Cr	676.28Cr
Total Liabilities And Equity	1.35TCr	1.31TCr	1.35TCr	1.4TCr	1.45TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.51Cr	7.48Cr	7.07Cr	6.72Cr	6.5Cr
ECS Total Common Shares Outstanding	8.51Cr	7.71Cr	7.06Cr	6.72Cr	6.5Cr
Book Value / Share	74.26	78.99	83.83	91.53	102.59
Tangible Book Value	235.18Cr	204.6Cr	193.3Cr	213.96Cr	265.71Cr
Tangible Book Value Per Share	27.65	26.54	27.37	31.85	40.89
Total Debt	419.44Cr	455.94Cr	527.13Cr	536.66Cr	495.54Cr
Net Debt	296.99Cr	444.41Cr	516.85Cr	524.72Cr	482.94Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-84.48L	-1.13Cr	-93.5L	-1.28Cr	-1.5Cr
Debt Equivalent Oper. Leases	93Cr	95Cr	105.3Cr	112.82Cr	117.15Cr
Minority Interest, Total (Incl. Fin. Div)	8.94Cr	11Cr	4.95Cr	5.29Cr	9.66Cr
Equity Method Investments, Total	54L	94L	84L	70L	58L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	19Cr	21Cr	22Cr	22Cr	22Cr
Land - (BS)	66Cr	73Cr	73Cr	74Cr	75Cr
Buildings, Total	603.02Cr	650.96Cr	675.62Cr	714Cr	767.12Cr
Machinery, Total	260.77Cr	275.99Cr	293.7Cr	306.63Cr	326.04Cr
Full Time Employees	68.1T	68.3T	71.2T	73.35T	76T
Part Time Employees	20.9T	21.1T	22.6T	23.35T	23T
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	94Cr	99Cr	68Cr	72Cr	114.21Cr
Depreciation & Amortization - CF	51Cr	53Cr	58Cr	57Cr	58Cr
Depreciation & Amortization, Total	51Cr	53Cr	58Cr	57Cr	58Cr
(Gain) Loss From Sale Of Asset	19.57L	-51.7L	6L	-62.5L	-99.2L
Asset Writedown & Restructuring Costs	-	1.44Cr	5.76Cr	-	-
Stock-Based Compensation (CF)	6.58Cr	7.37Cr	8.54Cr	8.77Cr	9.93Cr
Other Operating Activities, Total	1.02Cr	1.29Cr	-1.86Cr	15.12L	2.42Cr
Change In Accounts Receivable	-15Cr	-88.73L	-26Cr	-18Cr	6.74Cr
Change In Income Taxes	95.93L	-5.4Cr	-2.95Cr	-4.34Cr	1.27Cr
Change in Other Net Operating Assets	96Cr	-67Cr	-9.85Cr	12Cr	15Cr
Cash from Operations	236.02Cr	88Cr	100Cr	126.78Cr	206.71Cr
Capital Expenditure	-73Cr	-86Cr	-73Cr	-74Cr	-94Cr
Sale of Property, Plant, and Equipment	81.68L	2.54Cr	1.2Cr	2.42Cr	3.86Cr
Cash Acquisitions	-5.2Cr	-11Cr	-2.03Cr	-37.28L	-1.9Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-29.02L	1.97Cr	-	-	-
Investment in Marketable and Equity Securities, Total	-26.72L	-	-	-	-
Other Investing Activities, Total	-2.18Cr	14.57L	9.5Cr	-4.07Cr	1.31Cr
Cash from Investing	-80Cr	-91Cr	-65Cr	-76Cr	-91Cr
Long-Term Debt Issued, Total	80Cr	325.5Cr	71Cr	19Cr	221.02Cr
Total Debt Issued	80Cr	325.5Cr	71Cr	19Cr	221.02Cr
Long-Term Debt Repaid, Total	-96Cr	-303.79Cr	-8.94Cr	-8.55Cr	-264Cr
Total Debt Repaid	-96Cr	-303.79Cr	-8.94Cr	-8.55Cr	-264Cr
Issuance of Common Stock	1.23Cr	1.34Cr	1.41Cr	1.37Cr	1.51Cr
Repurchase of Common Stock	-21Cr	-122.09Cr	-83Cr	-55Cr	-67Cr
Common Dividends Paid	-1.73Cr	-6.59Cr	-5.84Cr	-5.55Cr	-5.33Cr
Common & Preferred Stock Dividends Paid	-1.73Cr	-6.59Cr	-5.84Cr	-5.55Cr	-5.33Cr
Other Financing Activities, Total	-1.21Cr	-1.27Cr	-5.71Cr	-43.76L	-60.94L
Cash from Financing	-38Cr	-106.9Cr	-32Cr	-49Cr	-114.49Cr
Foreign Exchange Rate Adjustments	7L	-5L	-84.24L	30.56L	-8L
Net Change in Cash	117.35Cr	-110.02Cr	2.19Cr	1.36Cr	1.03Cr
Supplemental Items
Cash Interest Paid	11Cr	7.56Cr	12Cr	20Cr	17Cr
Cash Income Tax Paid (Refund)	29Cr	36Cr	25Cr	26Cr	33Cr
Levered Free Cash Flow	109.07Cr	28Cr	12Cr	31Cr	96Cr
Unlevered Free Cash Flow	115.89Cr	33Cr	20Cr	44Cr	107.57Cr
Change In Net Working Capital	-47Cr	31Cr	39Cr	21Cr	-28Cr
Net Debt Issued / Repaid	-16Cr	22Cr	62Cr	9.96Cr	-43Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.76	6.56	4.99	5.35	7.41
Return on Total Capital	8.29	8.16	6.03	6.44	9.04
Return On Equity %	15.89	15.67	10.8	11.82	17.94
Return on Common Equity	15.92	15.95	11.24	11.89	17.82
Margin Analysis
Gross Profit Margin %	40.3	39.95	38.53	39.5	42.47
SG&A Margin	1	0.94	0.98	0.99	0.93
EBITDA Margin %	16.18	15.25	12.26	12.21	14.34
EBITA Margin %	11.76	11.03	7.92	8.23	10.65
EBIT Margin %	11.76	11.03	7.92	8.23	10.65
Income From Continuing Operations Margin %	8.24	7.81	4.9	5.04	7.35
Net Income Margin %	8.17	7.84	5.04	5.03	7.22
Net Avail. For Common Margin %	8.14	7.83	5.04	5.02	7.22
Normalized Net Income Margin	6.72	6.58	4.45	4.1	5.79
Levered Free Cash Flow Margin	9.44	2.22	0.93	2.17	6.06
Unlevered Free Cash Flow Margin	10.03	2.64	1.52	3.08	6.8
Asset Turnover
Asset Turnover	0.92	0.95	1.01	1.04	1.11
Fixed Assets Turnover	2.09	2.12	2.12	2.21	2.34
Receivables Turnover (Average Receivables)	7.03	7.27	7.12	6.71	7.17
Inventory Turnover (Average Inventory)	39.4	38.22	38.73	39.68	41.59
Short Term Liquidity
Current Ratio	1.32	1.14	1.33	1.4	1.27
Quick Ratio	1.19	0.94	1.11	1.17	1.04
Operating Cash Flow to Current Liabilities	0.95	0.45	0.52	0.63	0.94
Days Sales Outstanding (Average Receivables)	52.08	50.17	51.27	54.38	51.06
Days Outstanding Inventory (Average Inventory)	9.29	9.55	9.42	9.2	8.8
Average Days Payable Outstanding	26.86	29.49	28.66	26.42	25.03
Cash Conversion Cycle (Average Days)	34.51	30.23	32.03	37.16	34.83
Long Term Solvency
Total Debt/Equity	65.47	73.56	88.3	86.53	73.27
Total Debt / Total Capital	39.57	42.38	46.89	46.39	42.29
LT Debt/Equity	59.35	71.74	85.8	83.33	71.58
Long-Term Debt / Total Capital	35.87	41.33	45.56	44.68	41.31
Total Liabilities / Total Assets	52.46	52.66	55.76	55.6	53.26
EBIT / Interest Expense	12.46	16.35	8.34	5.67	8.98
EBITDA / Interest Expense	18.2	24	13.94	9.09	12.88
(EBITDA - Capex) / Interest Expense	11.5	13.96	8.18	5.51	7.85
Total Debt / EBITDA	2.11	2.23	2.97	2.85	2.05
Net Debt / EBITDA	1.5	2.17	2.91	2.78	2
Total Debt / (EBITDA - Capex)	3.34	3.83	5.07	4.7	3.37
Net Debt / (EBITDA - Capex)	2.37	3.73	4.97	4.6	3.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.59	9.37	5.99	6.59	10.82
Gross Profit, 1 Yr. Growth %	2.64	8.45	2.21	9.28	19.14
EBITDA, 1 Yr. Growth %	3.65	3.08	-14.76	6.11	30.19
EBITA, 1 Yr. Growth %	3.49	2.57	-23.9	10.77	43.36
EBIT, 1 Yr. Growth %	3.49	2.57	-23.9	10.77	43.36
Earnings From Cont. Operations, 1 Yr. Growth %	15.13	3.66	-33.48	9.49	61.7
Net Income, 1 Yr. Growth %	15.84	5.05	-31.87	6.24	59.11
Normalized Net Income, 1 Yr. Growth %	8.68	7.42	-28.35	-1.64	56.45
Diluted EPS Before Extra, 1 Yr. Growth %	20.37	7.55	-22.67	11.93	64.42
Accounts Receivable, 1 Yr. Growth %	10.77	1.02	15.52	10.93	-2.7
Inventory, 1 Yr. Growth %	19.09	8.62	5.65	-0.7	1.82
Net Property, Plant and Equip., 1 Yr. Growth %	6.86	9.32	2.1	2.91	6.59
Total Assets, 1 Yr. Growth %	15.5	-2.84	3.06	3.51	3.6
Tangible Book Value, 1 Yr. Growth %	51.66	-13	-5.52	10.69	24.19
Common Equity, 1 Yr. Growth %	14.77	-3.6	-2.78	3.86	8.41
Cash From Operations, 1 Yr. Growth %	64.08	-62.56	12.71	27.29	63.05
Capital Expenditures, 1 Yr. Growth %	15.33	17	-14.22	1.23	27.02
Levered Free Cash Flow, 1 Yr. Growth %	72.78	-74.31	-55.56	149.01	208.93
Unlevered Free Cash Flow, 1 Yr. Growth %	58.04	-71.22	-38.82	115.44	144.6
Dividend Per Share, 1 Yr. Growth %	-66.67	300	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.59	5.41	7.67	6.29	8.68
Gross Profit, 2 Yr. CAGR %	3.49	5.5	5.28	5.68	14.1
EBITDA, 2 Yr. CAGR %	5.45	3.37	-6.27	-4.9	17.54
EBITA, 2 Yr. CAGR %	5.19	3.03	-11.66	-8.19	26.01
EBIT, 2 Yr. CAGR %	5.19	3.03	-11.66	-8.19	26.01
Earnings From Cont. Operations, 2 Yr. CAGR %	9.28	9.25	-16.96	-14.66	33.06
Net Income, 2 Yr. CAGR %	10.03	10.31	-15.4	-14.92	30.02
Normalized Net Income, 2 Yr. CAGR %	8.35	7.87	-12.28	-16.05	24.05
Diluted EPS Before Extra, 2 Yr. CAGR %	15	13.78	-8.8	-6.97	35.66
Accounts Receivable, 2 Yr. CAGR %	7.15	5.78	8.03	13.2	3.89
Inventory, 2 Yr. CAGR %	13.35	13.74	7.12	2.42	0.55
Net Property, Plant and Equip., 2 Yr. CAGR %	8.52	8.08	5.65	2.51	4.74
Total Assets, 2 Yr. CAGR %	9.38	5.93	0.06	3.28	3.55
Tangible Book Value, 2 Yr. CAGR %	24.19	14.87	-9.34	2.26	17.24
Common Equity, 2 Yr. CAGR %	8.27	5.18	-3.19	0.49	6.11
Cash From Operations, 2 Yr. CAGR %	36.07	-21.62	-35.04	19.78	44.06
Capital Expenditures, 2 Yr. CAGR %	4.87	16.16	0.18	-6.81	13.4
Levered Free Cash Flow, 2 Yr. CAGR %	53.59	-33.39	-66.24	5.04	177.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	43.83	-32.56	-58.04	14.83	129.55
Dividend Per Share, 2 Yr. CAGR %	-29.29	15.47	100	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.55	5.48	5.6	7.31	7.78
Gross Profit, 3 Yr. CAGR %	2.51	5.11	4.39	6.6	9.99
EBITDA, 3 Yr. CAGR %	2.66	4.65	-3.07	-2.31	5.6
EBITA, 3 Yr. CAGR %	2.02	4.31	-6.87	-4.74	6.51
EBIT, 3 Yr. CAGR %	2.02	4.31	-6.87	-4.74	6.51
Earnings From Cont. Operations, 3 Yr. CAGR %	7.3	7.37	-7.4	-8.94	5.6
Net Income, 3 Yr. CAGR %	7.86	8.34	-6.06	-8.73	4.82
Normalized Net Income, 3 Yr. CAGR %	4.01	7.92	-5.88	-8.87	3.31
Diluted EPS Before Extra, 3 Yr. CAGR %	12.06	12.46	0.04	-2.36	12.48
Accounts Receivable, 3 Yr. CAGR %	4.92	5.07	8.93	8.99	7.63
Inventory, 3 Yr. CAGR %	11.82	11.75	10.97	4.45	2.22
Net Property, Plant and Equip., 3 Yr. CAGR %	7.69	8.79	6.05	4.73	3.85
Total Assets, 3 Yr. CAGR %	7.79	5.14	4.97	1.2	3.39
Tangible Book Value, 3 Yr. CAGR %	35.55	10.29	7.62	-3.1	9.1
Common Equity, 3 Yr. CAGR %	8.18	4.16	2.46	-0.9	3.06
Cash From Operations, 3 Yr. CAGR %	23.68	-11.5	-11.53	-18.71	32.75
Capital Expenditures, 3 Yr. CAGR %	9.47	8.77	5	0.53	3.32
Levered Free Cash Flow, 3 Yr. CAGR %	19.05	-15.37	-41.8	-34.27	50.49
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.28	-15.87	-34.71	-27.61	47.75
Dividend Per Share, 3 Yr. CAGR %	-20.63	25.99	10.06	58.74	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.03	5.3	5.18	5.8	6.82
Gross Profit, 5 Yr. CAGR %	3.84	4.01	3.61	5.34	8.17
EBITDA, 5 Yr. CAGR %	2.43	2.57	-1	0.72	4.7
EBITA, 5 Yr. CAGR %	1.54	1.7	-3.68	-0.88	5.11
EBIT, 5 Yr. CAGR %	1.54	1.7	-3.68	-0.88	5.11
Earnings From Cont. Operations, 5 Yr. CAGR %	4.88	5.74	-3.16	-2.05	7.04
Net Income, 5 Yr. CAGR %	6.76	7.14	-2.13	-1.64	6.99
Normalized Net Income, 5 Yr. CAGR %	3.76	4.17	-2.9	-2.39	5.11
Diluted EPS Before Extra, 5 Yr. CAGR %	10.21	10.61	3.2	4.24	13
Accounts Receivable, 5 Yr. CAGR %	5.83	3.94	6.15	8.25	6.89
Inventory, 5 Yr. CAGR %	10.41	10.53	9.92	7.92	6.68
Net Property, Plant and Equip., 5 Yr. CAGR %	8.28	7.58	6.87	6.23	5.52
Total Assets, 5 Yr. CAGR %	6.99	4.88	4.63	4.39	4.4
Tangible Book Value, 5 Yr. CAGR %	40.18	31.46	15.4	7.01	11.37
Common Equity, 5 Yr. CAGR %	8.25	6.08	3.48	2.67	3.91
Cash From Operations, 5 Yr. CAGR %	17.18	-7.9	-4.4	-0.11	7.52
Capital Expenditures, 5 Yr. CAGR %	14.03	10.48	5.65	2.25	8.28
Levered Free Cash Flow, 5 Yr. CAGR %	12.02	-19.62	-28.06	-7.67	8.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.94	-18.25	-22.65	-4.72	7.97
Dividend Per Share, 5 Yr. CAGR %	-12.94	14.87	14.87	14.87	5.92